rss
J Clin Pathol 2007;60:303-306 doi:10.1136/jcp.2006.037804
  • Original article

Survivin promoter polymorphism and cervical carcinogenesis

  1. A A Borbély1,
  2. M Murvai2,
  3. K Szarka1,
  4. J Kónya1,
  5. L Gergely2,
  6. Z Hernádi3,
  7. G Veress1
  1. 1Department of Medical Microbiology, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary
  2. 2Tumour Virus Research Group of the Hungarian Academy of Sciences, Debrecen, Hungary
  3. 3Department of Obstetrics and Gynecology, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary
  1. Correspondence to:
 Dr G Veress
 Department of Medical Microbiology, Medical and Health Science Centre, University of Debrecen, H-4012 Debrecen, POB 17, Hungary;veregy{at}dote.hu
  • Accepted 9 March 2006
  • Published Online First 19 May 2006

Abstract

Background: Survivin, a novel member of the inhibitor of apoptosis family, plays an important role in cell cycle regulation. A common polymorphism at the survivin gene promoter (G/C at position 31) was shown to be correlated with survivin gene expression in cancer cell lines.

Aim: To investigate whether this polymorphism could be involved in the development of human papillomavirus (HPV)-associated cervical carcinoma.

Methods: Survivin promoter polymorphism was detected in patients with cervical cancer, in patients with equivocal cytological atypia and in a control population using polymerase chain reaction (PCR-restriction fragment length polymorphism (RFLP) and PCR-single strand conformation polymorphism analysis. HPV was typed in patients with cervical cancer and cytological atypia using PCR-RFLP.

Results: No statistically significant differences were found in the genotype distributions of the survivin promoter variants among our study groups.

Conclusions: The survivin promoter polymorphism at position 31 may not represent an increased risk for the development of cervical cancer, at least in the population studied here.

Footnotes

  • Published Online First 19 May 2006

  • Funding: This study was supported by grants from the Hungarian Scientific Research Fund (OTKA T049191 and T046608).

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jcp.2006.037804v1
    2. 60/3/303 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.